Oximio, Georgia, is proud to continue its successful cooperation with Tbilisi State Medical University (TSMU) by participating in the American MD Programme initiative. This programme is a partnership between TSMU and Emory University School of Medicine...
The Ministry of Health of Ukraine has announced the introduction of new changes to the procedures for conducting clinical trials of medicinal products and the examination of clinical trial materials from 13 June 2024. This welcome change is the result of the dedicated...
Global Pharma Supply Chain & Logistics Forum 19-20 September 2024 Munich, Germany Join Oximio at the Global Pharma Supply Chain & Logistics Forum in Munich. This year’s events boasts a full calendar of hot topics covering the pharma supply chain and its...
Effective from April 2024, an update to the Resolution of Cabinet of Ministers of Ukraine #1402 has been made which affects the import and export of medical equipment containing ozone-depleting substances and fluorinated greenhouse gases. It states that all equipment,...
9-12 June Cape Town, South Africa Rob van den Bergh, Oximio’s Regional Sales Director for Africa is delighted to be heading to the 46th Annual SAPICS Conference in Cape Town. Tackling the distribution challenges faced by healthcare providers in Africa across its...
Oximio is delighted to announce a significant expansion of its capabilities in the UK by attaining a Wholesale Distribution Authorisation (WDA) licence from the Medicines and Healthcare Products Regulatory Agency (MHRA). The WDA licence assigns Oximio the...
